教員情報 - 山口　央 | 埼玉医科大学

教員情報トップぺージ

メールアドレス

学術雑誌

専門医・専門性キーワード

（最終更新日：2022-07-11 20:22:47）

  ヤマグチ　オウ   YAMAGUCHI OU
  山口　央
   所属   埼玉医科大学医学部国際医療センター　呼吸器内科

職種専任講師

■ メールアドレス

■ 学術雑誌

1.	学術雑誌(原著)	Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers. 2021/03/15
2.	学術雑誌(総説)	Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumab. 2021/02
3.	学術雑誌(症例報告)	Detection of pseudoprogression with [ 18 F]-FDG-PET in a patient with pulmonary large cell neuroendocrine carcinoma who received anti-PD-1 treatment 2020/10/22
4.	学術雑誌(症例報告)	Osimertinib induced cardiomyopathy 2020/09/25
5.	学術雑誌(原著)	Tumor metabolic volume by ¹⁸F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 >/= 50 2020/09/14
6.	学術雑誌(原著)	Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events 2020/05/01
7.	学術雑誌(原著)	Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer 2020/04/01
8.	学術雑誌(原著)	Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer 2020/03/07
9.	学術雑誌(症例報告)	Psuedoprogression mimicking hyperprogressive disease after pembrolizumab treatment in a patient with lung cancer 2020/01
10.	学術雑誌(症例報告)	Unexpected response of extramedullary plasmacytoma in patients with lung cancer who received nivolumab 2019/12/01
11.	学術雑誌(原著)	Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer 2019/10
12.	学術雑誌(原著)	Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation 2019/05
13.	学術雑誌(原著)	Clinical significance of primary prophylactic pegylated-granulocyte-colony stimulating factor after the administration of ramucirumab plus docetaxel in patients with previously treated non-small cell lung cancer 2019/04
14.	学術雑誌(原著)	Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer 2019/04
15.	学術雑誌(原著)	Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients 2019/04
16.	学術雑誌(総説)	特発性肺線維症(IPF)と喫煙 2012/09
17.	学術雑誌(原著)	15歳で発見された高分化胎児型腺癌の1例 2011/10
18.	学術雑誌(原著)	吸入ステロイドが著効した挿管後気管狭窄の1例 2010/09
19.	学術雑誌(総説)	【治療の優先順位はこうつける!】心疾患合併のCOPD β遮断薬をやめる?続ける? 2008/09
5件表示
全件表示(19件)

■ 専門医・専門性キーワード

専門医取得の有無：無し
肺癌
分子標的薬
免疫チェックポイント阻害薬
免疫関連有害事象
間質性肺炎